Clinical Trials Logo
  1. Home
  2. Kidney Failure, Chronic
  3. NCT04827290
  4. Details
NCT04827290 Clinical Trial

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Kidney Failure, Chronic Clinical Trial

— CKD AGE  

Official title:
Assessment of the Effect of Restriction on Alimentary AGE (Advanced Glycation Products) in Progression of Chronic Kidney Disease (CKD)

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04827290
Other study ID # CKD AGE
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2024
Est. completion date September 1, 2025

Study information
Verified date April 2024
Source Centre Hospitalier Saint Joseph Saint Luc de Lyon
Contact Fanny Doroszewski
Phone 0033478618398
Email fdoroszewski@chsjsl.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 66
Est. completion date September 1, 2025
Est. primary completion date August 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Patients with a grade IIIA-B CKD (GFR with CKD-EPI = 30 mL/min and < 60mL/min) - Informed consent signed - Aged 18 to 89 years Exclusion Criteria: - Protected adult - Acute renal failure - Patient already on a low-AGE diet (< 1kU AGE/day) following a dietetic consultation - Current participation in another interventional research

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Low-AGE diet
Low-AGE diet during 24 months
• High-AGE diet
High-AGE diet during 24 months

Locations
Country Name City State
France Centre Hospitalier Saint Joseph Saint Luc Lyon

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Glomerular Filtration Rate Glomerular Filtration Rate estimated by the CKD-EPI formula with a blood sample At 24 months
Secondary Proteinuria Proteinuria (g/24h) found in the 24-hour urine At 24 months
See also
  Status Clinical Trial Phase
Completed NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ N/A
Completed NCT02922361 - Spending and Outcomes for Complex Medicare Advantage Patients
Completed NCT02235571 - iChoose Decision Kidney Aid for End-Stage Renal Disease Patients N/A
Completed NCT01922843 - A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis Phase 2
Completed NCT01933789 - Improving Communication About Serious Illness N/A
Completed NCT01930396 - Use of Tinzaparin for Anticoagulation in Hemodialysis Phase 4
Not yet recruiting NCT01674660 - Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients N/A
Completed NCT01209403 - Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients Phase 4
Not yet recruiting NCT01157260 - The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease Phase 4
Completed NCT00753116 - Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension Phase 1
Recruiting NCT00532688 - N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure Phase 2/Phase 3
Completed NCT00534144 - Comparison Between Effects of Two Iron Preparations on Protein in the Urine Phase 1
Completed NCT00528788 - How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Phase 4
Completed NCT00382044 - Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients N/A
Completed NCT00226902 - Vascular Reactivity in Kidney Disease Patients N/A
Recruiting NCT00235287 - Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease Phase 4
Completed NCT00224081 - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Phase 4
Completed NCT00071214 - Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis Phase 3
Completed NCT00049907 - Cardiac and Renal Disease Study (CARDS) N/A
Completed NCT00006297 - Risk Factors for CV Disease in a Dialysis Cohort N/A